MEDPLUS.NS
Price
Day trading desk
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
3 more panels on MEDPLUS.NS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Valuation & profitability ratios
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $68.35B | $60.87B | $55.74B | $45.29B | +12.3% |
| Operating revenue | $68.35B | $60.87B | $55.74B | $45.29B | +12.3% |
| Cost of revenue | $50.85B | $46.41B | $43.92B | $35.58B | +9.6% |
| Gross profit | $17.51B | $14.47B | $11.82B | $9.71B | +21.0% |
| Selling, general & admin | $1.53B | $1.33B | $1.23B | $887.09M | +15.4% |
| Total operating expense | $14.08B | $11.92B | $10.50B | $8.84B | +18.1% |
| Operating income | $3.43B | $2.55B | $1.32B | $873.32M | +34.4% |
| Net interest income | -$941.33M | -$929.60M | -$754.97M | -$552.39M | -1.3% |
| Pre-tax income | $2.75B | $1.83B | $734.43M | $471.63M | +50.2% |
| Tax provision | $557.24M | $330.56M | $78.66M | -$29.42M | +68.6% |
| Net income | $2.20B | $1.50B | $654.73M | $497.63M | +46.1% |
| Net income to common | $2.20B | $1.50B | $654.73M | $497.63M | +46.1% |
| Basic EPS | 18.33 | 12.57 | 5.48 | 4.17 | +45.8% |
| Diluted EPS | 18.29 | 12.52 | 5.45 | 4.17 | +46.1% |
| EBIT | $3.96B | $2.86B | $1.70B | $1.30B | +38.5% |
| EBITDA | $6.79B | $5.36B | $3.94B | $3.12B | +26.7% |
| Basic shares | 119.83M | 119.59M | 119.39M | 119.31M | +0.2% |
| Diluted shares | 120.10M | 120.02M | 120.02M | 119.65M | +0.1% |
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.98B | $860.52M | $912.09M | $2.28B | — | +130.6% |
| Cash & short-term investments | $5.92B | $4.40B | $1.65B | $2.89B | — | +34.7% |
| Accounts receivable | $230.38M | $79.56M | $122.51M | $66.84M | — | +189.6% |
| Inventory | $13.82B | $13.45B | $13.40B | $11.44B | — | +2.7% |
| Total current assets | $20.69B | $18.44B | $15.68B | $14.81B | — | +12.2% |
| Property, plant & equipment | $15.78B | $12.62B | $12.03B | $11.18B | — | +25.0% |
| Goodwill & intangibles | $493.30M | $508.95M | $515.30M | $489.89M | — | -3.1% |
| Total assets | $39.33B | $33.60B | $30.05B | $27.97B | — | +17.0% |
| Total current liabilities | $6.89B | $5.77B | $5.26B | $4.77B | — | +19.5% |
| Current debt | $0 | $0 | $0 | $0 | — | — |
| Long-term debt | — | — | — | — | $0 | — |
| Total debt | $14.24B | $11.20B | $10.10B | $9.00B | — | +27.2% |
| Total liabilities | $19.58B | $16.20B | $14.27B | $13.06B | — | +20.8% |
| Retained earnings | $6.52B | $4.30B | $2.79B | $2.14B | — | +51.6% |
| Shareholder equity | $19.75B | $17.41B | $15.78B | $14.91B | — | +13.5% |
| Working capital | $13.79B | $12.67B | $10.42B | $10.04B | — | +8.9% |
| Net tangible assets | $19.26B | $16.90B | $15.26B | $14.42B | — | +14.0% |
| Shares issued | 120.05M | 119.69M | 119.54M | 119.31M | — | +0.3% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | $2.75B | $1.83B | $734.43M | $471.63M | +50.2% |
| Depreciation & amortisation | $2.83B | $2.50B | $2.24B | $1.82B | +13.2% |
| Stock-based compensation | $30.47M | $68.69M | $141.04M | $221.19M | -55.6% |
| Change in working capital | -$992.91M | $486.09M | -$2.31B | -$2.16B | -304.3% |
| Operating cash flow | $4.96B | $5.40B | $1.44B | $904.08M | -8.3% |
| Capital expenditure | -$1.23B | -$594.50M | -$843.99M | -$1.69B | -106.9% |
| Investing cash flow | -$1.28B | -$3.18B | -$827.99M | $4.29B | +59.8% |
| Financing cash flow | -$2.56B | -$2.28B | -$1.98B | -$1.70B | -12.1% |
| Free cash flow | $3.73B | $4.81B | $593.38M | -$785.97M | -22.5% |
| End cash position | $1.98B | $860.52M | $912.09M | $2.28B | +130.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $18.80B | $18.64B | $18.06B | $15.43B | $15.10B | +0.8% |
| Operating revenue | $18.80B | $18.64B | $18.06B | $15.43B | $15.10B | +0.8% |
| Cost of revenue | $14.19B | $13.71B | $13.34B | $11.40B | $11.09B | +3.5% |
| Gross profit | $4.60B | $4.93B | $4.72B | $4.03B | $4.01B | -6.7% |
| Total operating expense | $4.05B | $4.00B | $3.87B | $3.38B | $3.29B | +1.2% |
| Operating income | $553.21M | $932.27M | $858.75M | $651.12M | $721.65M | -40.7% |
| Net interest income | -$332.70M | -$334.80M | -$308.29M | -$273.65M | -$268.41M | +0.6% |
| Pre-tax income | $418.77M | $803.42M | $732.87M | $527.66M | $611.16M | -47.9% |
| Tax provision | $87.10M | $163.69M | $154.99M | $104.23M | $97.96M | -46.8% |
| Net income | $331.76M | $639.83M | $578.07M | $423.58M | $513.35M | -48.1% |
| Net income to common | $331.76M | $639.83M | $578.07M | $423.58M | $513.35M | -48.1% |
| Basic EPS | 2.76 | 5.33 | 4.82 | 3.54 | 4.32 | -48.2% |
| Diluted EPS | 2.76 | 5.33 | 4.81 | 3.53 | 4.30 | -48.2% |
| EBIT | $751.47M | $1.14B | $1.04B | $801.31M | $879.57M | -34.0% |
| EBITDA | $1.53B | $1.90B | $1.77B | $1.46B | $1.52B | -19.3% |
| Basic shares | 120.20M | 120.04M | 119.93M | 119.66M | 118.83M | +0.1% |
| Diluted shares | 120.20M | 120.04M | 120.18M | 119.99M | 119.38M | +0.1% |
| Line item | 2026-03-31 | 2025-03-31 | YoY |
|---|---|---|---|
| Cash & equivalents | $1.98B | $860.52M | +130.6% |
| Cash & short-term investments | $5.92B | $4.40B | +34.7% |
| Accounts receivable | $230.38M | $79.56M | +189.6% |
| Inventory | $13.82B | $13.45B | +2.7% |
| Total current assets | $20.69B | $18.44B | +12.2% |
| Property, plant & equipment | $15.78B | $12.62B | +25.0% |
| Goodwill & intangibles | $493.30M | $508.95M | -3.1% |
| Total assets | $39.33B | $33.60B | +17.0% |
| Total current liabilities | $6.89B | $5.77B | +19.5% |
| Current debt | $0 | $0 | — |
| Total debt | $14.24B | $11.20B | +27.2% |
| Total liabilities | $19.58B | $16.20B | +20.8% |
| Retained earnings | $6.52B | $4.30B | +51.6% |
| Shareholder equity | $19.75B | $17.41B | +13.5% |
| Working capital | $13.79B | $12.67B | +8.9% |
| Net tangible assets | $19.26B | $16.90B | +14.0% |
| Shares issued | 120.05M | 119.69M | +0.3% |
Newly listed companies often have nothing on file until their first annual report.
Analyst targets & ownership
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Headlines
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.